Giansun Precision Technology Group
001400
Heilongjiang Tianyouwei Electronics
603202
Joy Kie Corporation
300994
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
CN Stock MarketDetailed Quotes
603202 Heilongjiang Tianyouwei Electronics
- 116.00
- +22.50+24.06%
Market Closed Apr 24 15:00 CST
18.56BMarket Cap16.33P/E (TTM)
140.00High114.11Low228.93KlotVolume140.00Open93.50Pre Close2.83BTurnover70.35%Turnover Ratio16.33P/E (Static)160.00MShares140.0052wk High2.90P/B3.78BFloat Cap114.1152wk Low0.00Limit Up32.54MShs Float140.00Historical High0.00Limit Down27.69%Amplitude114.11Historical Low--Dividend TTM123.69Avg Price103.69KlotAsk--Div YieldTTM100Lot Size97.73KlotBid
Heilongjiang Tianyouwei Electronics Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 29.90%4.46B | 32.59%3.22B | 2.04B | 74.27%3.44B | 2.43B | 68.93%1.97B | 25.03%1.17B | 933.81M |
| Operating revenue | 29.90%4.46B | 32.59%3.22B | --2.04B | 74.27%3.44B | --2.43B | 68.93%1.97B | 25.03%1.17B | --933.81M |
| Other operating revenue | 35.67%17.94M | ---- | --6.93M | 79.62%13.22M | ---- | 21.08%7.36M | 255.63%6.08M | --1.71M |
| Total operating cost | 28.85%3.21B | 1.43B | 62.33%2.49B | 44.25%1.54B | 17.09%1.06B | 909.01M | ||
| Operating cost | 31.42%2.88B | ---- | --1.28B | 61.35%2.19B | ---- | 49.67%1.36B | 18.19%907.94M | --768.18M |
| Operating tax surcharges | 66.19%28.9M | ---- | --15.79M | 77.06%17.39M | ---- | 77.72%9.82M | 55.54%5.53M | --3.55M |
| Operating expense | -17.37%115.13M | ---- | --48.84M | 182.23%139.33M | ---- | 41.11%49.37M | -7.57%34.98M | --37.85M |
| Administration expense | 18.41%44.68M | ---- | --20.04M | 47.20%37.73M | ---- | 56.10%25.63M | 20.35%16.42M | --13.64M |
| Financial expense | -262.74%-22.68M | ---- | ---6.13M | -189.91%-6.25M | ---- | -72.27%6.95M | 12.95%25.07M | --22.2M |
| -Interest expense (Financial expense) | -2.43%16.59M | ---- | --8.41M | -11.06%17M | ---- | -26.55%19.12M | 11.39%26.03M | --23.37M |
| -Interest Income (Financial expense) | -1,124.09%-29.72M | ---- | ---9.22M | -101.26%-2.43M | ---- | -82.32%-1.21M | -881.94%-661.59K | ---67.38K |
| Research and development | 46.84%163.57M | ---- | --72.64M | 31.70%111.4M | ---- | 13.73%84.58M | 16.97%74.37M | --63.58M |
| Credit Impairment Loss | 4.79%-21.84M | ---- | --391.69K | 22.28%-22.94M | ---- | -1,228.54%-29.52M | 63.79%-2.22M | ---6.14M |
| Asset Impairment Loss | 33.42%-2.18M | ---- | ---4.79M | 55.96%-3.27M | ---- | -251.74%-7.43M | 151.32%4.9M | ---9.54M |
| Other net revenue | 47.84%70.26M | 0 | 35.96M | 407.82%47.53M | 0 | -63.43%9.36M | 363.03%25.59M | 5.53M |
| Fair value change income | ---- | ---- | ---- | ---- | ---- | 47.91%74.76K | 9,050.47%50.54K | ---564.69 |
| Invest income | -49.32%2.22M | ---- | ---280.71K | -25.14%4.39M | ---- | 2.45%5.86M | 979.72%5.72M | --529.68K |
| -Including: Investment income associates | -160.29%-1.08M | ---- | ---280.71K | -314.08%-413.81K | ---- | ---99.93K | ---- | ---- |
| Asset deal income | 716.93%151.44K | ---- | ---2.23K | 201.10%18.54K | ---- | 88.35%-18.34K | 6.31%-157.39K | ---168K |
| Other revenue | 32.56%91.91M | ---- | --40.64M | 71.64%69.34M | ---- | 133.41%40.4M | -16.98%17.31M | --20.85M |
| Operating profit | 33.39%1.32B | 47.76%992.41M | 642.9M | 122.29%992.39M | 671.63M | 246.56%446.44M | 324.77%128.82M | 30.33M |
| Add:Non operating Income | 169.85%450.77K | ---- | --61.18K | -79.87%167.04K | ---- | 111.25%829.67K | 1,023.84%392.74K | --34.95K |
| Less:Non operating expense | -56.97%222.33K | ---- | --140.29K | -81.52%516.7K | ---- | 219.35%2.8M | -18.30%875.68K | --1.07M |
| Total profit | 33.46%1.32B | 47.88%992.53M | 642.82M | 123.19%992.04M | 671.18M | 246.33%444.47M | 338.16%128.34M | 29.29M |
| Less:Income tax cost | 25.68%187.84M | ---- | --92.4M | 212.62%149.47M | ---- | 295.03%47.81M | 261.80%12.1M | ---7.48M |
| Net profit | 34.84%1.14B | 550.42M | 112.41%842.57M | 241.26%396.66M | 216.11%116.23M | 36.77M | ||
| Net profit from continuing operation | 34.84%1.14B | ---- | --550.42M | 112.41%842.57M | ---- | 241.26%396.66M | 216.11%116.23M | --36.77M |
| Less:Minority Profit | -172.91%-342.21K | ---- | ---123.59K | 714.78%469.35K | ---- | -137.47%-76.34K | 55,372.55%203.72K | ---368.58 |
| Net profit of parent company owners | 34.96%1.14B | 50.80%851.11M | --550.55M | 112.26%842.1M | --564.41M | 241.93%396.74M | 215.55%116.03M | --36.77M |
| Earning per share | ||||||||
| Basic earning per share | 34.90%9.47 | ---- | --4.59 | 110.81%7.02 | ---- | --3.33 | ---- | ---- |
| Diluted earning per share | 34.90%9.47 | ---- | --4.59 | 110.81%7.02 | ---- | --3.33 | ---- | ---- |
| Other composite income | -61.73%-15.14M | -6.76M | 15.36%-9.36M | 62.98%-11.06M | -1,106.41%-29.86M | 2.97M | ||
| Other composite income of parent company owners | -61.73%-15.14M | ---- | ---6.76M | 15.36%-9.36M | ---- | 62.98%-11.06M | -1,106.41%-29.86M | --2.97M |
| Total composite income | 34.54%1.12B | 543.67M | 116.08%833.21M | 346.46%385.61M | 117.35%86.37M | 39.74M | ||
| Total composite income of parent company owners | 34.66%1.12B | ---- | --543.79M | 115.91%832.74M | ---- | 347.61%385.68M | 116.83%86.17M | --39.74M |
| Total composite income of minority owners | -172.91%-342.21K | ---- | ---123.59K | 714.78%469.35K | ---- | -137.47%-76.34K | 55,372.55%203.72K | ---368.58 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | Unqualified opinion | -- | Unqualified opinion | Unqualified opinion | Unqualified opinion |
| Auditor | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | Lixin Certified Public Accountants (Special General Partnership) | Lixin Certified Public Accountants (Special General Partnership) | Lixin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.